Back

Effects of irbesartan for renal failure in the patients with chronic heart failure and preserved systolic function and atrial fibrillation

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Basic Science - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2018

13 More presentations in this session

Presentation thumbnail
Elamipretide restores protein and mRNA expression levels of S100A1 in left ventricular myocardium of dogs with chronic heart failure
Professor H. Sabbah (Detroit, US)
Abstract
Presentation thumbnail
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats
Miss M. Krasnova (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Introducing SGLT2 inhibitors during hospitalization. Safety and outocmes.
Doctor F. Camacho Jurado (Puerto Real, ES)
Abstract
Presentation thumbnail
Outcome evaluation of the association of sacubitril/valsartan and iSGLT2 in diabetic patients with heart failure with reduced ejection fraction.
Doctor F. Camacho Jurado (Puerto Real, ES)
Abstract
Presentation thumbnail
Outcome evaluation of Sacubitril/Valsartan in patients with Heart Failure and reduced ejection fraction with regular follow-up meetings in a Spanish heart failure day-hospital.
Doctor F. Camacho Jurado (Puerto Real, ES)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Basic Science - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources